Igor Dolgalev
Impact in
- Ophthalmology top 0.5%
- Ocular Oncology and Treatments
- Oncology top 2%
- Cutaneous Melanoma Detection and Management
- Cancer Cells and Metastasis
Papers in
-
- Single-cell and spatial transcriptomics 4
- Histone Deacetylase Inhibitors Research 4
- Genomics and Chromatin Dynamics 4
- Melanoma and MAPK Pathways 3
- Immunology 13
- Immune Cell Function and Interaction 5
- Immune cells in cancer 4
- Immunotherapy and Immune Responses 3
- Co-authors
- Adriana Heguy (22 shared papers)Michelle B. Crosby (1 shared paper)Boris C. Bastian (1 shared paper)Joan M. O’Brien (1 shared paper)Klaus J. Busam (1 shared paper)Werner Wackernagel (1 shared paper)Mert Sozen (1 shared paper)Ritu Roy (1 shared paper)
- Journals
- PLoS ONE (3 papers)Blood (3 papers)Schizophrenia Research (2 papers)Nature Cell Biology (2 papers)Science Advances (2 papers)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
Igor Dolgalev
55 papers receiving 3.2k citations
Igor Dolgalev's Hit Papers
Peers
Comparison fields: 5 of 105
- Ophthalmology 597
- Oncology 931
- Immunology 561
- Cancer Research 353
- Molecular Biology 1.5k
Countries citing papers authored by Igor Dolgalev
This map shows the geographic impact of Igor Dolgalev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Dolgalev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Dolgalev more than expected).
Fields of papers citing papers by Igor Dolgalev
This network shows the impact of papers produced by Igor Dolgalev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Dolgalev. The network helps show where Igor Dolgalev may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Dolgalev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutations in GNA11 in Uveal Melanoma Hit paper breakdown → | 2010 | 1058 |
| 2 | 2014 | 232 | |
| 3 | 2018 | 209 | |
| 4 | 2014 | 167 | |
| 5 | 2011 | 154 | |
| 6 | 2019 | 153 | |
| 7 | 2017 | 127 | |
| 8 | 2020 | 71 | |
| 9 | 2019 | 68 | |
| 10 | 2017 | 64 | |
| 11 | 2020 | 63 | |
| 12 | 2021 | 56 | |
| 13 | 2016 | 55 | |
| 14 | 2015 | 53 | |
| 15 | 2008 | 51 | |
| 16 | 2017 | 50 | |
| 17 | 2019 | 48 | |
| 18 | 2016 | 47 | |
| 19 | 2023 | 42 | |
| 20 | 2017 | 40 |
About Igor Dolgalev
Igor Dolgalev is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 59 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Immune Cell Function and Interaction (5 papers), Single-cell and spatial transcriptomics (4 papers), Immune cells in cancer (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Genomics and Chromatin Dynamics (4 papers), Immunotherapy and Immune Responses (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Ophthalmology (597 citations), Oncology (931 citations), Immunology (561 citations), Cancer Research (353 citations) and Molecular Biology (1.5k citations). Igor Dolgalev has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Adriana Heguy, Michelle B. Crosby, Boris C. Bastian, Joan M. O’Brien, Klaus J. Busam, Werner Wackernagel, Mert Sozen, Ritu Roy, Nancy Bouvier and Gary Green. Their work appears in journals such as PLoS ONE, Blood, Schizophrenia Research, Nature Cell Biology and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.